DOLPHMED

Dolphin Medical Services Ltd.

6.54+0.0 (+0.00%)
19 Oct, 12:00 AM

Annual Reports and Financial Documents

Dolphin Medical Services Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
20132014201520162017201820192020202120222023202420252026
Annual ReportsFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025—
Quarterly Results—————
Conference Calls——————————————
Presentations——————————————

Corporate Announcements and Regulatory Filings

Dolphin Medical Services Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Closure of Trading Window30 Sept 2026
    Closure of Trading Window
    Closure of Trading Wndow
  2. Change in Management21 Sept 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    BM outcome for Appointment of Mr. Amarandhar Reddy Kotha and other matters
  3. Change in Management Control21 Sept 2026
    Announcement under Regulation 30 (LODR)-Change in Management Control
    BM outcome for Appointment of Mr. Amarandhar Reddy Kotha and other matters
  4. Board Meeting20 Sept 2026
    Board Meeting Intimation for To Consider And Approve The Appointment Of Mr. Amarandhar Reddy Kotha (DIN: 07425226) As Chairman And Promoter Director Of The Company And Other Items
    Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/09/2026 ,inter alia, to consider and approve To consider and approve ....
  5. Outcome without intimation12 Sept 2026
    Board Meeting Outcome for Intimation Of Resignation Of Mr GV MOHAN PRASAD, Mrs. M LAKSHMI SUDHA And Mr. DWARAKANATH MADALA
    Intimation of Resignation of Mr GV MOHAN PRASAD, Mrs. M LAKSHMI SUDHA and Mr. DWARAKANATH MADALA as directors of the company.
  6. Change in Management12 Sept 2026
    Announcement under Regulation 30 (LODR)-Change in Management
    Resignation of Mr GV MOHAN PRASAD, Mrs. M LAKSHMI SUDHA and Mr. DWARAKANATH MADALA
  7. General3 Sept 2026
    Intimation Of Extension Of AGM
    Intimation of Extension of AGM
  8. General28 Aug 2026
    Post-Offer Advertisement
    Rarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Post-Offer advertisement under Regulation 18(12) in terms of the Securities and Exchange Board ....
  9. Outcome of Board Meeting14 Aug 2026
    Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended June 30, 2026
    Board meeting outcome
  10. Board Meeting9 Aug 2026
    Board Meeting Intimation for BM Intimation For BM Is Scheduled To Be Held On Thursday, August 14, 2026, Inter Alia, To Consider & Approve The Unaudited Standalone Financial Results Of The Company For The 1St Quarter Ended June 30, 2026 Of The Financial Year 2026-27
    Dolphin Medical Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Board Meeting Intimation ....
  11. Open Offer30 Jul 2026
    Updates on Open Offer
    Rarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Pre-Offer advertisement cum corrigendum to the Public Announcement and Detailed Public Statement ....
  12. General27 Jul 2026
    Letter of Offer
    Rarever Financial Advisors Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Letter of Offer ("LOF") to the public shareholders of Dolphin Medical Services Ltd ("Target Company").
  13. Resignation of Chief Financial Officer (CFO)25 Jul 2026
    Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
    Ms. Vaishnavi Sharma, Chief Financial Officer of the Company has tendered resignation and the same is intimated herewith.
  14. Resignation of Company Secretary / Compliance Officer25 Jul 2026
    Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
    Ms. Vaishnavi Sharma, Company Secretary and Compliance officer of the Company has tendered resignation and the same is intimated herewith.
  15. Open Offer16 Jul 2026
    Updates on Open Offer (Identified Date)
    Rarever Financial Advisors Pvt Ltd ("Manager to the Offer") has informed BSE regarding the identified date for the purpose of determining the names of the shareholders to whom the Letter ....
  16. Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 20183 Jul 2026
    Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
    certificate under Reg 74(5) from RTA
  17. General1 Jun 2026
    Draft Letter of Offer
    Rarever Financial Advisors Pvt. Ltd. ("Manager to the Offer") has submitted to BSE a copy of Draft Letter of Offer to the Public Shareholders of Dolphin Medical Services Ltd ("Target Company").
  18. Reg.24(A)-Annual Secretarial Compliance30 May 2026
    Compliances-Reg.24(A)-Annual Secretarial Compliance
    Annual Compliance Report under Regulation 24A of SEBI (LODR) for financial year ended 31 march, 2026.
  19. General23 May 2026
    Detailed Public Statement (Corrigendum)
    Rarever Financial Advisors Pvt. Ltd ("Manager to the Offer") has submitted to BSE a copy of Corrigendum to the Detailed Public Statement for the attention of the Public Shareholders of ....
  20. Open Offer - Updates23 May 2026
    Announcement under Regulation 30 (LODR)-Open Offer - Updates
    Rarever Financial Advisors Private Limited (hereafter referred to as 'Manager to the Offer'), are hereby submitting the Detailed Public Statement made by us on behalf of Mr. Amarandhar ....

Frequently Asked Questions

Where can I download the annual report of Dolphin Medical Services Ltd.?
Annual reports of Dolphin Medical Services Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Dolphin Medical Services Ltd.?
Quarterly earnings results and presentations of Dolphin Medical Services Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Dolphin Medical Services Ltd. publish earnings call transcripts?
Earnings call transcripts of Dolphin Medical Services Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Dolphin Medical Services Ltd.?
Investor presentations and annual day presentations of Dolphin Medical Services Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Dolphin Medical Services Ltd.?
Corporate announcements and regulatory filings of Dolphin Medical Services Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Dolphin Medical Services Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Dolphin Medical Services Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Dolphin Medical Services Ltd.?
The ISIN (International Securities Identification Number) of Dolphin Medical Services Ltd. is INE796B01013. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Dolphin Medical Services Ltd. listed?
Dolphin Medical Services Ltd. is listed on NSE and BSE. The NSE symbol is DOLPHMED and the BSE code is -.
Where can I find the shareholding pattern of Dolphin Medical Services Ltd.?
The quarterly shareholding pattern of Dolphin Medical Services Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Dolphin Medical Services Ltd. on Sharpely?
Share price data for Dolphin Medical Services Ltd. is updated as of 19 Oct 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.